rh α gala Search Results


rh alpha gal a cho cells  (ATCC)
99
ATCC rh alpha gal a cho cells
Rh Alpha Gal A Cho Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rh alpha gal a cho cells/product/ATCC
Average 99 stars, based on 1 article reviews
rh alpha gal a cho cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
rh α gala  (R&D Systems)
93
R&D Systems rh α gala
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Rh α Gala, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rh α gala/product/R&D Systems
Average 93 stars, based on 1 article reviews
rh α gala - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
recombinant rh-α-gal-a enzyme  (Sanofi)
90
Sanofi recombinant rh-α-gal-a enzyme
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Recombinant Rh α Gal A Enzyme, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rh-α-gal-a enzyme/product/Sanofi
Average 90 stars, based on 1 article reviews
recombinant rh-α-gal-a enzyme - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rh-α-gal a agalsidase-β  (Genzyme)
90
Genzyme rh-α-gal a agalsidase-β
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Rh α Gal A Agalsidase β, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rh-α-gal a agalsidase-β/product/Genzyme
Average 90 stars, based on 1 article reviews
rh-α-gal a agalsidase-β - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rh α -gal a enzyme atb100  (JCR Pharmaceuticals)
90
JCR Pharmaceuticals rh α -gal a enzyme atb100
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Rh α Gal A Enzyme Atb100, supplied by JCR Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rh α -gal a enzyme atb100/product/JCR Pharmaceuticals
Average 90 stars, based on 1 article reviews
rh α -gal a enzyme atb100 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
recombinant rh-alpha-gal a fabrazyme  (Genzyme)
90
Genzyme recombinant rh-alpha-gal a fabrazyme
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Recombinant Rh Alpha Gal A Fabrazyme, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rh-alpha-gal a fabrazyme/product/Genzyme
Average 90 stars, based on 1 article reviews
recombinant rh-alpha-gal a fabrazyme - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
recombinant rh-alpha-gal a replagal  (Shire Plc)
90
Shire Plc recombinant rh-alpha-gal a replagal
FD patients’ cohort description. Activity of <t> α-GalA </t> (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.
Recombinant Rh Alpha Gal A Replagal, supplied by Shire Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rh-alpha-gal a replagal/product/Shire Plc
Average 90 stars, based on 1 article reviews
recombinant rh-alpha-gal a replagal - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hederagenin - 3-o-β-d- galactosyl( 1→3)-β-d-glucosyl( 1→3)-α-l-rhamnosyl(1→2)-α-l-arabinoside  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier
oleanolic acid - 3-o-α-l-rhamnosyl(1→6)β-d- galactosyl( 1→3)-β-d-glucosyl( 1→3)-α-l-rhamnosyl(1→2)-α-l-arabinoside  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier
oleanolic acid - 3-o-β-d- galactosyl( 1→3)-β-d-glucosyl( 1→3)-α-l-rhamnosyl(1→2)-α-l-arabinoside  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier
3-o-β-d- galactosyl( 1→3)-β-d-glucosyl( 1→3)-α-l-rhamnosyl(1→2)-α-l-arabinosyl-oleanolic acid - 28-o-α-l-rhamnosyl(1→4)β-d-glucosyl( 1→6)-β-d-glucosid  (Aladdin Scientific Corporation)
N/A
   Buy from Supplier

Image Search Results


FD patients’ cohort description. Activity of α-GalA (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.

Journal: International Journal of Molecular Sciences

Article Title: Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

doi: 10.3390/ijms25116024

Figure Lengend Snippet: FD patients’ cohort description. Activity of α-GalA (μmol/hL) was measured in dried blood spots (DBSs) at enrollment in the study. NT indicates non-treated FD patient. ERT = enzyme replacement therapy, PC = pharmacological chaperone. N.D. = not available, N.A. = not applicable.

Article Snippet: Briefly, plates were coated with rh-α-GalA (#6146-GH, R&D, Systems), which binds to IgG antibodies against the α-GalA recombinant enzyme (diluted 1:50 in PBS with 5% low fat milk).

Techniques: Activity Assay, Mutagenesis

Plasmatic activity levels. Histograms n panel ( A ) represent plasmatic α-GalA activity ± SEM (nmol/mL·h) in controls (white bars), FD naïve patients (light gray bars), and FD patients treated with ERT (white bars with dots). In panel ( B ), α-GalA activity values are separated according to sex. Significance was assessed by one-way ANOVA non-parametric test, Kruskal–Wallis multiple comparisons (* p < 0.05).

Journal: International Journal of Molecular Sciences

Article Title: Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

doi: 10.3390/ijms25116024

Figure Lengend Snippet: Plasmatic activity levels. Histograms n panel ( A ) represent plasmatic α-GalA activity ± SEM (nmol/mL·h) in controls (white bars), FD naïve patients (light gray bars), and FD patients treated with ERT (white bars with dots). In panel ( B ), α-GalA activity values are separated according to sex. Significance was assessed by one-way ANOVA non-parametric test, Kruskal–Wallis multiple comparisons (* p < 0.05).

Article Snippet: Briefly, plates were coated with rh-α-GalA (#6146-GH, R&D, Systems), which binds to IgG antibodies against the α-GalA recombinant enzyme (diluted 1:50 in PBS with 5% low fat milk).

Techniques: Activity Assay

Anti-α-GalA-IgG antibody concentration. Concentration of IgG antibodies determined by ELISA in plasma samples of control individuals and patients in treatment or not with ERT, collected at Ti, T6, T12 months. ( A ) Average values (mean ± SEM) for each group of patients at each collection time. ( B ) Individual values (mean of two replicates) for each subject of the study at all assessed times. ( C ) Time course of anti-α-GalA antibodies for the four patients in panel ( B ), who presented antibody levels close or above the threshold. In all graphs, dotted lines represent threshold.

Journal: International Journal of Molecular Sciences

Article Title: Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

doi: 10.3390/ijms25116024

Figure Lengend Snippet: Anti-α-GalA-IgG antibody concentration. Concentration of IgG antibodies determined by ELISA in plasma samples of control individuals and patients in treatment or not with ERT, collected at Ti, T6, T12 months. ( A ) Average values (mean ± SEM) for each group of patients at each collection time. ( B ) Individual values (mean of two replicates) for each subject of the study at all assessed times. ( C ) Time course of anti-α-GalA antibodies for the four patients in panel ( B ), who presented antibody levels close or above the threshold. In all graphs, dotted lines represent threshold.

Article Snippet: Briefly, plates were coated with rh-α-GalA (#6146-GH, R&D, Systems), which binds to IgG antibodies against the α-GalA recombinant enzyme (diluted 1:50 in PBS with 5% low fat milk).

Techniques: Concentration Assay, Enzyme-linked Immunosorbent Assay, Control